1
|
Veerman AJ, Supriyadi E, Sutaryo S. Developing leukemia protocols in cooperation between the Netherlands and Indonesia. PEDIATRIC HEMATOLOGY ONCOLOGY JOURNAL 2020. [DOI: 10.1016/j.phoj.2020.03.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
2
|
Dillmon MS, Kennedy EB, Anderson MK, Brodersen M, Cohen H, D′Amato SL, Davis P, Doshi G, Genschaw S, Makhoul I, Ormsby W, Panikkar R, Peng E, Raez LE, Ronnen EA, Wimbiscus B, Reff M. Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. J Clin Oncol 2020; 38:633-644. [DOI: 10.1200/jco.19.02297] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
PURPOSE To provide standards for medically integrated dispensing of oral anticancer drugs and supportive care medications. METHODS An Expert Panel was formed, and a systematic review of the literature on patient-centered best practices for the delivery of oral anticancer and supportive care drugs was performed to April 2019 using PubMed and Google Scholar. Available patient-centered standards, including one previously developed by the National Community Oncology Dispensing Association (NCODA), were considered for endorsement. Public comments were solicited and considered in preparation of the final manuscript. RESULTS A high-quality systematic review that was current to May 2016 was adopted into the evidence base. Five additional primary studies of multifaceted interventions met the inclusion criteria. These studies generally included a multicomponent intervention, often led by an oncology pharmacist, and also included patient education and regular follow-up and monitoring. These interventions resulted in significant improvements to patient quality and safety and demonstrated improvements in adherence and other patient outcomes. CONCLUSION The findings of the systematic review were consistent with the NCODA patient-centered standards for patient relationships and education, adherence, safety, collection of data, documentation, and other areas. NCODA standards were adopted and used as basis for these American Society of Clinical Oncology/NCODA standards. Additional information is available at www.asco.org/mid-standards .
Collapse
Affiliation(s)
| | | | | | | | | | | | - Patty Davis
- Oncology Hematology Associates, Springfield, MO
| | | | - Stuart Genschaw
- Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI
| | - Issam Makhoul
- University of Arkansas for Medical Sciences, Little Rock, AK
| | | | | | - Eileen Peng
- Regional Cancer Care Associates, East Brunswick, NJ
| | - Luis E. Raez
- Memorial Healthcare System/Florida International University, Pembroke Pines, FL
| | | | - Bill Wimbiscus
- National Community Oncology Dispensing Association, Cazenovia, NY
| | - Michael Reff
- National Community Oncology Dispensing Association, Cazenovia, NY
| |
Collapse
|
3
|
Pediatric oncology-hematology outreach: Evaluation of patient consultations by teleconferences between Indonesian and Dutch academic hospitals. PEDIATRIC HEMATOLOGY ONCOLOGY JOURNAL 2018. [DOI: 10.1016/j.phoj.2018.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
4
|
Rossell N, Salaverria C, Hernandez A, Alabi S, Vasquez R, Bonilla M, Lam CG, Ribeiro R, Reis R. Community resources support adherence to treatment for childhood cancer in El Salvador. J Psychosoc Oncol 2018; 36:319-332. [PMID: 29452054 DOI: 10.1080/07347332.2018.1427174] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
OBJECTIVE In order to reduce nonadherence and treatment abandonment of children with cancer in El Salvador, institutions located nearby the patients' homes were involved to provide support. Methodological approach: Health clinics and municipality offices in the patients' communities were asked to assist families who were not promptly located after missing hospital appointments, or those whose financial limitations were likely to impede continuation of treatment. Data was collected about the number of contacted institutions, the nature of help provided, staff's time investments, and parents' perceptions about the intervention. FINDINGS Local institutions (133 from 206 contacts) conducted home visits (83), and/or provided parents with money (55) or transportation (60). Parents found this support essential for continuing the treatment but they also encountered challenges regarding local institutions' inconsistencies. Nonadherence and abandonment decreased. IMPLICATIONS Economic burden was reduced on both the families and the hospital. Involvement of external institutions might become regular practice to support families of children with cancer.
Collapse
Affiliation(s)
- Nuria Rossell
- a Amsterdam Institute for Social Science Research (AISSR), Amsterdam University , Amsterdam , The Netherlands.,b Department of Oncology , Benjamin Bloom Hospital , San Salvador , El Salvador
| | - Carmen Salaverria
- b Department of Oncology , Benjamin Bloom Hospital , San Salvador , El Salvador
| | - Angelica Hernandez
- b Department of Oncology , Benjamin Bloom Hospital , San Salvador , El Salvador
| | - Soad Alabi
- b Department of Oncology , Benjamin Bloom Hospital , San Salvador , El Salvador
| | - Roberto Vasquez
- b Department of Oncology , Benjamin Bloom Hospital , San Salvador , El Salvador
| | - Miguel Bonilla
- c International Outreach Program, St. Jude Children's Research Hospital , Memphis , Tennessee , USA
| | - Catherine G Lam
- c International Outreach Program, St. Jude Children's Research Hospital , Memphis , Tennessee , USA.,d Department of Oncology , St. Jude Children's Research Hospital , Memphis , Tennessee , USA.,e College of Medicine, University of Tennessee , Memphis , Tennessee , USA
| | - Raul Ribeiro
- d Department of Oncology , St. Jude Children's Research Hospital , Memphis , Tennessee , USA.,e College of Medicine, University of Tennessee , Memphis , Tennessee , USA
| | - Ria Reis
- a Amsterdam Institute for Social Science Research (AISSR), Amsterdam University , Amsterdam , The Netherlands.,f Leiden University Medical Center , Leiden , The Netherlands.,g School of Child and Adolescent Health, University of Cape Town, The Children's Institute , Cape Town , South Africa
| |
Collapse
|
5
|
Graham H, Tokhi M, Duke T. Scoping review: strategies of providing care for children with chronic health conditions in low- and middle-income countries. Trop Med Int Health 2016; 21:1366-1388. [PMID: 27554327 DOI: 10.1111/tmi.12774] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES To identify and review strategies of providing care for children living with chronic health conditions in low- and middle-income countries. METHODS We searched MEDLINE and Cochrane EPOC databases for papers evaluating strategies of providing care for children with chronic health conditions in low- or middle-income countries. Data were systematically extracted using a standardised data charting form, and analysed according to Arksey and O'Malley's 'descriptive analytical method' for scoping reviews. RESULTS Our search identified 71 papers addressing eight chronic conditions; two chronic communicable diseases (HIV and TB) accounted for the majority of papers (n = 37, 52%). Nine (13%) papers reported the use of a package of care provision strategies (mostly related to HIV and/or TB in sub-Saharan Africa). Most papers addressed a narrow aspect of clinical care provision, such as patient education (n = 23) or task-shifting (n = 15). Few papers addressed the strategies for providing care at the community (n = 10, 15%) or policy (n = 6, 9%) level. Low-income countries were under-represented (n = 24, 34%), almost exclusively involving HIV interventions in sub-Saharan Africa (n = 21). Strategies and summary findings are described and components of future models of care proposed. CONCLUSIONS Strategies that have been effective in reducing child mortality globally are unlikely to adequately address the needs of children with chronic health conditions in low- and middle-income settings. Current evidence mostly relates to disease-specific, narrow strategies, and more research is required to develop and evaluate the integrated models of care, which may be effective in improving the outcomes for these children.
Collapse
Affiliation(s)
- Hamish Graham
- Centre for International Child Health, Royal Children's Hospital, University of Melbourne, MCRI, Melbourne, VIC, Australia.
| | - Mariam Tokhi
- Victorian Aboriginal Health Service, Melbourne, VIC, Australia
| | - Trevor Duke
- Centre for International Child Health, Royal Children's Hospital, University of Melbourne, MCRI, Melbourne, VIC, Australia
| |
Collapse
|
6
|
|
7
|
Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol 2015; 26:650-5. [PMID: 25202926 DOI: 10.1097/cco.0000000000000125] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
PURPOSE OF REVIEW Acute lymphoblastic leukemia is the most common pediatric cancer. The cure rate of this disease is over 80% in developed countries utilizing protocols with very tolerable toxicity. Several factors contributed to this success, including the implementation of large collaborative clinical trials and the better understanding of disease biology allowing for risk-stratified treatment. We will review the current state of the treatment of acute lymphoblastic leukemia in low-income and medium-income countries. RECENT FINDINGS The picture differs from country to country, but recent advances have been made in many countries and the cure rates have improved significantly. Tackling problems such as access to care, abandonment of treatment and toxicity of protocols and the development of centers of excellence are critical for continued improvement. Twinning with programs in developed countries and the creation of regional collaborative groups will allow the implementation of risk-directed therapy and better supportive care. SUMMARY The experience in low-income countries shows that a structured approach to the treatment of acute lymphoblastic leukemia results in improved survival.
Collapse
|
8
|
Zerillo JA, Pham TH, Kadlubek P, Severson JA, Mackler E, Jacobson JO, Blayney DW. Administration of Oral Chemotherapy: Results From Three Rounds of the Quality Oncology Practice Initiative. J Oncol Pract 2015; 11:e255-62. [DOI: 10.1200/jop.2014.001842] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The collection of oral chemotherapy test measure data is feasible, and improvement opportunities exist for patients who are prescribed oral chemotherapy.
Collapse
Affiliation(s)
- Jessica A. Zerillo
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Trang H. Pham
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Pamela Kadlubek
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Jane Alcyne Severson
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Emily Mackler
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Joseph O. Jacobson
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| | - Douglas W. Blayney
- Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute, Boston, MA; American Society of Clinical Oncology, Alexandria, VA; Michigan Oncology Quality Consortium, Ann Arbor, MI; and Stanford Cancer Institute, Stanford, CA
| |
Collapse
|